The wealthier nations of the world are focusing their genomics research efforts primarily on projects that will address their major health problems — they are placing a big emphasis on stratified medicine studies — and they are not putting much effort into working with low and middle-income countries on their big concerns, according to the Organization for Economic Cooperation and Development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.